ID   M4K4_HUMAN              Reviewed;        1239 AA.
AC   O95819; O75172; Q9NST7;
DT   28-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2003, sequence version 2.
DT   02-NOV-2010, entry version 106.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase kinase 4;
DE            EC=2.7.11.1;
DE   AltName: Full=HPK/GCK-like kinase HGK;
DE   AltName: Full=MAPK/ERK kinase kinase kinase 4;
DE            Short=MEK kinase kinase 4;
DE            Short=MEKKK 4;
DE   AltName: Full=Nck-interacting kinase;
GN   Name=MAP4K4; Synonyms=HGK, KIAA0687, NIK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4 AND 5), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Macrophage;
RX   MEDLINE=99107863; PubMed=9890973; DOI=10.1074/jbc.274.4.2118;
RA   Yao Z., Zhou G., Wang X.S., Brown A., Diener K., Gan H., Tan T.-H.;
RT   "A novel human STE20-related protein kinase, HGK, that specifically
RT   activates the c-Jun N-terminal kinase signaling pathway.";
RL   J. Biol. Chem. 274:2118-2125(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Glioblastoma;
RX   MEDLINE=22499944; PubMed=12612079;
RX   DOI=10.1128/MCB.23.6.2068-2082.2003;
RA   Wright J.H., Wang X., Manning G., LaMere B.J., Le P., Zhu S.,
RA   Khatry D., Flanagan P.M., Buckley S.D., Whyte D.B., Howlett A.R.,
RA   Bischoff J.R., Lipson K.E., Jallal B.;
RT   "The STE20 kinase HGK is broadly expressed in human tumor cells and
RT   can modulate cellular transformation, invasion, and adhesion.";
RL   Mol. Cell. Biol. 23:2068-2082(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 38-1239 (ISOFORM 2).
RC   TISSUE=Brain;
RX   MEDLINE=98403880; PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 262-1239 (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 700-1239.
RC   TISSUE=Brain;
RA   Saito T., Seki N., Hori T.;
RT   "Isolation, expression profile and chromosome assignment of a novel
RT   serine/threonine kinase gene.";
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   INTERACTION WITH ATL1.
RX   MEDLINE=22275851; PubMed=12387898; DOI=10.1016/S0014-5793(02)03467-1;
RA   Luan Z., Zhang Y., Liu A., Man Y., Cheng L., Hu G.;
RT   "A novel GTP-binding protein hGBP3 interacts with NIK/HGK.";
RL   FEBS Lett. 530:233-238(2002).
RN   [7]
RP   INTERACTION WITH RAP2A, AND SUBCELLULAR LOCATION.
RX   PubMed=14966141; DOI=10.1074/jbc.C300542200;
RA   Machida N., Umikawa M., Takei K., Sakima N., Myagmar B.E., Taira K.,
RA   Uezato H., Ogawa Y., Kariya K.;
RT   "Mitogen-activated protein kinase kinase kinase kinase 4 as a putative
RT   effector of Rap2 to activate the c-Jun N-terminal kinase.";
RL   J. Biol. Chem. 279:15711-15714(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-629; SER-631 AND
RP   SER-805, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-181; SER-602; SER-629;
RP   SER-631; SER-639; SER-801; SER-805 AND SER-900, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-692 AND SER-696, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-639, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; SER-326; SER-629;
RP   SER-631; SER-639; SER-644; SER-656; SER-712; SER-715; SER-805;
RP   THR-828; SER-842; SER-855; THR-857; SER-913 AND THR-915, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-629; SER-631; SER-639;
RP   SER-656; SER-658 AND SER-805, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5; THR-181; THR-187;
RP   THR-319; TYR-321; TYR-323; SER-324; SER-326; SER-350; THR-351;
RP   SER-600; SER-629; SER-631; SER-639; SER-644; SER-656; THR-657;
RP   SER-677; SER-679; SER-680; SER-681; SER-683; SER-684; SER-692;
RP   SER-696; SER-708; SER-712; SER-715; SER-800; SER-805; THR-828;
RP   SER-830; THR-840; SER-842; SER-844; SER-852; SER-853; SER-855;
RP   SER-868; SER-900; THR-915 AND THR-1230, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-639; SER-800; SER-805
RP   AND SER-900, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-712, AND VARIANT [LARGE SCALE
RP   ANALYSIS] VAL-682 (ISOFORM 3).
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine kinase that may play a role in the
CC       response to environmental stress and cytokines such as TNF-alpha.
CC       Appears to act upstream of the JUN N-terminal pathway.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- SUBUNIT: Interacts with the SH3 domain of the adapter proteins Nck
CC       (By similarity). Interacts (via its CNH regulatory domain) with
CC       ATL1 (via the N-terminal region). Interacts with RAP2A (GTP-bound
CC       form preferentially).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Tumor-associated;
CC         IsoId=O95819-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95819-2; Sequence=VSP_007054, VSP_007057;
CC       Name=3;
CC         IsoId=O95819-3; Sequence=VSP_007056, VSP_007057;
CC         Note=Variant in position: 682:D->V;
CC       Name=4; Synonyms=HGK-S;
CC         IsoId=O95819-4; Sequence=VSP_007054, VSP_007055, VSP_007057,
CC                                  VSP_007058;
CC       Name=5; Synonyms=HGK-L;
CC         IsoId=O95819-5; Sequence=VSP_007054, VSP_007055, VSP_007056,
CC                                  VSP_007057, VSP_007058;
CC   -!- TISSUE SPECIFICITY: Appears to be ubiquitous. Expressed in all
CC       tissue types examined. Isoform 5 appears to be more abundant in
CC       the brain. Isoform 4 is predominant in the liver, skeletal muscle
CC       and placenta.
CC   -!- PTM: Phosphorylated upon DNA damage, probably by ATM or ATR.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily.
CC   -!- SIMILARITY: Contains 1 CNH domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF096300; AAD16137.1; -; mRNA.
DR   EMBL; AY212247; AAO32626.1; -; mRNA.
DR   EMBL; AB014587; BAA31662.1; -; mRNA.
DR   EMBL; AL137755; CAB70907.2; -; mRNA.
DR   EMBL; AB013385; BAA33714.1; -; mRNA.
DR   IPI; IPI00006752; -.
DR   IPI; IPI00219799; -.
DR   IPI; IPI00219800; -.
DR   IPI; IPI00219802; -.
DR   IPI; IPI00639883; -.
DR   PIR; T46481; T46481.
DR   RefSeq; NP_004825.2; -.
DR   RefSeq; NP_663719.1; -.
DR   RefSeq; NP_663720.1; -.
DR   UniGene; Hs.431550; -.
DR   ProteinModelPortal; O95819; -.
DR   SMR; O95819; 24-297.
DR   IntAct; O95819; 5.
DR   STRING; O95819; -.
DR   PhosphoSite; O95819; -.
DR   PRIDE; O95819; -.
DR   Ensembl; ENST00000347699; ENSP00000314363; ENSG00000071054.
DR   GeneID; 9448; -.
DR   KEGG; hsa:9448; -.
DR   UCSC; uc002tbd.1; human.
DR   UCSC; uc002tbe.1; human.
DR   UCSC; uc002tbg.1; human.
DR   CTD; 9448; -.
DR   GeneCards; GC02P102313; -.
DR   HGNC; HGNC:6866; MAP4K4.
DR   HPA; HPA008476; -.
DR   MIM; 604666; gene.
DR   PharmGKB; PA30612; -.
DR   eggNOG; prNOG18377; -.
DR   HOVERGEN; HBG036506; -.
DR   PhylomeDB; O95819; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; ceramidepathway; Ceramide signaling pathway.
DR   Pathway_Interaction_DB; ephbfwdpathway; EPHB forward signaling.
DR   Pathway_Interaction_DB; tnfpathway; TNF receptor signaling pathway.
DR   NextBio; 35392; -.
DR   ArrayExpress; O95819; -.
DR   Bgee; O95819; -.
DR   CleanEx; HS_MAP4K4; -.
DR   Genevestigator; O95819; -.
DR   GermOnline; ENSG00000071054; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0005083; F:small GTPase regulator activity; IEA:InterPro.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0046328; P:regulation of JNK cascade; IDA:UniProtKB.
DR   GO; GO:0006950; P:response to stress; IDA:UniProtKB.
DR   InterPro; IPR001180; Citron.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   1239       Mitogen-activated protein kinase kinase
FT                                kinase kinase 4.
FT                                /FTId=PRO_0000086280.
FT   DOMAIN       25    289       Protein kinase.
FT   DOMAIN      926   1213       CNH.
FT   NP_BIND      31     39       ATP (By similarity).
FT   REGION      858   1212       Mediates interaction with RAP2A.
FT   ACT_SITE    153    153       Proton acceptor (By similarity).
FT   BINDING      54     54       ATP (By similarity).
FT   MOD_RES       5      5       Phosphoserine.
FT   MOD_RES     181    181       Phosphothreonine.
FT   MOD_RES     187    187       Phosphothreonine.
FT   MOD_RES     319    319       Phosphothreonine.
FT   MOD_RES     321    321       Phosphotyrosine.
FT   MOD_RES     323    323       Phosphotyrosine.
FT   MOD_RES     324    324       Phosphoserine.
FT   MOD_RES     326    326       Phosphoserine.
FT   MOD_RES     350    350       Phosphoserine.
FT   MOD_RES     351    351       Phosphothreonine.
FT   MOD_RES     600    600       Phosphoserine.
FT   MOD_RES     602    602       Phosphoserine.
FT   MOD_RES     629    629       Phosphoserine.
FT   MOD_RES     631    631       Phosphoserine.
FT   MOD_RES     639    639       Phosphoserine.
FT   MOD_RES     644    644       Phosphoserine.
FT   MOD_RES     656    656       Phosphoserine.
FT   MOD_RES     657    657       Phosphothreonine.
FT   MOD_RES     658    658       Phosphoserine.
FT   MOD_RES     677    677       Phosphoserine.
FT   MOD_RES     679    679       Phosphoserine.
FT   MOD_RES     680    680       Phosphoserine.
FT   MOD_RES     681    681       Phosphoserine.
FT   MOD_RES     683    683       Phosphoserine.
FT   MOD_RES     684    684       Phosphoserine.
FT   MOD_RES     692    692       Phosphoserine.
FT   MOD_RES     696    696       Phosphoserine.
FT   MOD_RES     708    708       Phosphoserine.
FT   MOD_RES     712    712       Phosphoserine.
FT   MOD_RES     715    715       Phosphoserine.
FT   MOD_RES     800    800       Phosphoserine.
FT   MOD_RES     801    801       Phosphoserine.
FT   MOD_RES     805    805       Phosphoserine.
FT   MOD_RES     828    828       Phosphothreonine.
FT   MOD_RES     830    830       Phosphoserine.
FT   MOD_RES     840    840       Phosphothreonine.
FT   MOD_RES     842    842       Phosphoserine.
FT   MOD_RES     844    844       Phosphoserine.
FT   MOD_RES     852    852       Phosphoserine.
FT   MOD_RES     853    853       Phosphoserine.
FT   MOD_RES     855    855       Phosphoserine.
FT   MOD_RES     857    857       Phosphothreonine.
FT   MOD_RES     868    868       Phosphoserine.
FT   MOD_RES     900    900       Phosphoserine.
FT   MOD_RES     913    913       Phosphoserine.
FT   MOD_RES     915    915       Phosphothreonine.
FT   MOD_RES    1230   1230       Phosphothreonine.
FT   VAR_SEQ     495    525       Missing (in isoform 2, isoform 4 and
FT                                isoform 5).
FT                                /FTId=VSP_007054.
FT   VAR_SEQ     569    622       Missing (in isoform 4 and isoform 5).
FT                                /FTId=VSP_007055.
FT   VAR_SEQ     623    623       V -> VQWSHLASLKNNVSPVSRSHSFSDPSPKFAHHHLRS
FT                                QDPCPPSRSEVLSQSSDSKSEAPDPTQKAWSRSDSDEVPPR
FT                                V (in isoform 3 and isoform 5).
FT                                /FTId=VSP_007056.
FT   VAR_SEQ     740    740       A -> AGEV (in isoform 2, isoform 3,
FT                                isoform 4 and isoform 5).
FT                                /FTId=VSP_007057.
FT   VAR_SEQ    1112   1112       H -> HVRKNPHSM (in isoform 4 and isoform
FT                                5).
FT                                /FTId=VSP_007058.
FT   VARIANT     712    712       S -> T.
FT                                /FTId=VAR_040746.
FT   CONFLICT    658    658       S -> SS (in Ref. 3 and 4).
FT   CONFLICT    839    839       Q -> R (in Ref. 2; AAO32626).
SQ   SEQUENCE   1239 AA;  142101 MW;  8FBBE2F9ABEEC757 CRC64;
     MANDSPAKSL VDIDLSSLRD PAGIFELVEV VGNGTYGQVY KGRHVKTGQL AAIKVMDVTE
     DEEEEIKLEI NMLKKYSHHR NIATYYGAFI KKSPPGHDDQ LWLVMEFCGA GSITDLVKNT
     KGNTLKEDWI AYISREILRG LAHLHIHHVI HRDIKGQNVL LTENAEVKLV DFGVSAQLDR
     TVGRRNTFIG TPYWMAPEVI ACDENPDATY DYRSDLWSCG ITAIEMAEGA PPLCDMHPMR
     ALFLIPRNPP PRLKSKKWSK KFFSFIEGCL VKNYMQRPST EQLLKHPFIR DQPNERQVRI
     QLKDHIDRTR KKRGEKDETE YEYSGSEEEE EEVPEQEGEP SSIVNVPGES TLRRDFLRLQ
     QENKERSEAL RRQQLLQEQQ LREQEEYKRQ LLAERQKRIE QQKEQRRRLE EQQRREREAR
     RQQEREQRRR EQEEKRRLEE LERRRKEEEE RRRAEEEKRR VEREQEYIRR QLEEEQRHLE
     VLQQQLLQEQ AMLLECRWRE MEEHRQAERL QRQLQQEQAY LLSLQHDHRR PHPQHSQQPP
     PPQQERSKPS FHAPEPKAHY EPADRAREVE DRFRKTNHSS PEAQSKQTGR VLEPPVPSRS
     ESFSNGNSES VHPALQRPAE PQVPVRTTSR SPVLSRRDSP LQGSGQQNSQ AGQRNSTSIE
     PRLLWERVEK LVPRPGSGSS SGSSNSGSQP GSHPGSQSGS GERFRVRSSS KSEGSPSQRL
     ENAVKKPEDK KEVFRPLKPA DLTALAKELR AVEDVRPPHK VTDYSSSSEE SGTTDEEDDD
     VEQEGADEST SGPEDTRAAS SLNLSNGETE SVKTMIVHDD VESEPAMTPS KEGTLIVRQT
     QSASSTLQKH KSSSSFTPFI DPRLLQISPS SGTTVTSVVG FSCDGMRPEA IRQDPTRKGS
     VVNVNPTNTR PQSDTPEIRK YKKRFNSEIL CAALWGVNLL VGTESGLMLL DRSGQGKVYP
     LINRRRFQQM DVLEGLNVLV TISGKKDKLR VYYLSWLRNK ILHNDPEVEK KQGWTTVGDL
     EGCVHYKVVK YERIKFLVIA LKSSVEVYAW APKPYHKFMA FKSFGELVHK PLLVDLTVEE
     GQRLKVIYGS CAGFHAVDVD SGSVYDIYLP THIQCSIKPH AIIILPNTDG MELLVCYEDE
     GVYVNTYGRI TKDVVLQWGE MPTSVAYIRS NQTMGWGEKA IEIRSVETGH LDGVFMHKRA
     QRLKFLCERN DKVFFASVRS GGSSQVYFMT LGRTSLLSW
//
